Adjunctive therapies during veno-venous extracorporeal membrane oxygenation
- PMID: 29732187
- PMCID: PMC5911547
- DOI: 10.21037/jtd.2017.10.08
Adjunctive therapies during veno-venous extracorporeal membrane oxygenation
Abstract
Veno-venous extracorporeal membrane oxygenation (VV ECMO) restores gas exchanges in severely hypoxemic patients. The need for adjunctive therapies usually originates either from refractory hypoxemia during ECMO (defined as the persistence of low blood oxygen levels despite extracorporeal support) or from the attempt to give a specific therapy for acute respiratory distress syndrome (ARDS). In this review, therapeutic strategies to treat refractory and persistent hypoxemia during ECMO are evaluated. In the second part, therapies that can be added on top of VV ECMO to address inflammation and altered vascular permeability in ARDS are examined. The therapies currently available often allow for an effective treatment of hypoxemia during ECMO. ARDS is still lacking a specific therapy, with low-grade evidence sustaining the majority of currently used drugs.
Keywords: Veno-venous extracorporeal membrane oxygenation (VV ECMO); acute respiratory distress syndrome (ARDS); hypoxemia.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
References
-
- Abdelsalam M, Cheifetz IM. Goal-Directed Therapy for Severely Hypoxic Patients With Acute Respiratory Distress Syndrome: Permissive Hypoxemia. Respir Care 2010;55:1483-90. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources